Stereotaxis
[PUBLIC]Service & Cobot Robotics · HQ: St. Louis, MO · Est. 1990 · 1 model registered · 2 deployments
As of Sep 2026, DEPLOY verifies Stereotaxis: 1 model, 2 deployments across 2 regions, 1 active incident. 3 sources back the record.
Ownership
PUBLIC
Capital / Funding
Undisclosed
Headquarters
St. Louis, MO
IP / Patents
Undisclosed
Platform Models
1
Audited Incidents
1
Overview
Stereotaxis is an American medical device company based in St. Louis, Missouri, developing magnetic navigation technology for robotic cardiology procedures. Its Genesis RMN system uses robotically controlled magnets to guide flexible catheters with magnetic tips during cardiac ablation procedures, and received FDA clearance and NMPA approval in China.
Safety profile within acceptable range for category. Limited public funding data for capital position assessment.
- PUBLIC
- SURGICAL
Key Facts
Safety & Regulatory Posture
1 incident on record (1 minor). Most recent: Apr 2026.
Evidentiary Regulatory Filings & Recalls
fda_510kfda 510k · us_fdacleared2024-01-01Linked models: Genesis RMN / GenesisX
Leadership & Founders
Current Program Leadership & Executives
Chairman & CEO
Partnerships & Commercial Deployments
Operator Customers & Fleet Integrators
Platform Models
Deployments
Incidents affecting Stereotaxis
Sectors & Applications
FAQ
What is Stereotaxis?
Stereotaxis is an American medical device company based in St. Louis, Missouri, developing magnetic navigation technology for robotic cardiology procedures. Its Genesis RMN system uses robotically controlled magnets to guide flexible catheters with magnetic tips during cardiac ablation procedures, and received FDA clearance and NMPA approval in China.
What does Stereotaxis make?
Stereotaxis has 1 robot model on the DEPLOY registry: Genesis RMN / GenesisX (Stereotaxis builds both physical robots and the AI that runs them).
Is Stereotaxis publicly traded?
Yes. Stereotaxis is publicly traded on public markets, per the DEPLOY registry.
Who competes with Stereotaxis?
On the DEPLOY registry, peer companies to Stereotaxis building in the same form factors include Brainlab, EndoQuest Robotics, Intuitive Surgical, LEM Surgical.
Who is the CEO of Stereotaxis?
David Fischel is the ceo of Stereotaxis, per the DEPLOY registry.
How can I invest in Stereotaxis?
Stereotaxis is publicly traded (public markets), so its shares can be bought through any broker.
Where is Stereotaxis headquartered?
Stereotaxis is headquartered in St. Louis, MO, USA.
Who owns Stereotaxis?
Stereotaxis is publicly held by its shareholders.
Where does Stereotaxis operate robots?
Stereotaxis operates 2 verified deployments, including at Global (multiple sites), United States.
How many robots has Stereotaxis deployed?
DEPLOY has 2 verified Stereotaxis deployments on record at sites including Global (multiple sites), United States. That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.
Is Stereotaxis a top robotics company?
On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Stereotaxis ranks in roughly the top 48% of companies tracked by the registry.
When was Stereotaxis founded?
Stereotaxis was founded in 1990.
Are there any incidents involving Stereotaxis?
1 active incident involving Stereotaxis is on the DEPLOY registry. Each is a sourced, append-only record; retracted incidents are suppressed from this view.
Is Stereotaxis safe?
Stereotaxis has 1 active incident on record in the DEPLOY registry. 1 incident on record (1 minor). Most recent: Apr 2026. Retracted incidents are excluded from this count.